Skip to content
healthcare.dev

CASGEVY

NDC 51167-290, exagamglogene autotemcel, injection, suspension, from Vertex Pharmaceuticals Incorporated.

Product NDC
51167-290
Status
Listed
Labeler
Vertex Pharmaceuticals Incorporated
Dosage form
INJECTION, SUSPENSION
Route
INTRAVENOUS
Product type
CELLULAR THERAPY
Marketing category
BLA
Application
BLA125787
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51167-290 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EXAGAMGLOGENE AUTOTEMCEL13000000 1/mL
Package NDCNDC-11Package
51167-290-09511670290099 VIAL in 1 CARTON (51167-290-09) / 20 mL in 1 VIAL (51167-290-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 51167-290 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51167-290 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51167-290. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.